NAPHAZOLINE Drug Patent Profile
✉ Email this page to a colleague
When do Naphazoline patents expire, and when can generic versions of Naphazoline launch?
Naphazoline is a drug marketed by Rising and Altaire Pharms Inc and is included in three NDAs.
The generic ingredient in NAPHAZOLINE is naphazoline hydrochloride; pheniramine maleate. There are eight drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the naphazoline hydrochloride; pheniramine maleate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Naphazoline
A generic version of NAPHAZOLINE was approved as naphazoline hydrochloride; pheniramine maleate by ALTAIRE PHARMS INC on September 27th, 2010.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for NAPHAZOLINE?
- What are the global sales for NAPHAZOLINE?
- What is Average Wholesale Price for NAPHAZOLINE?
Summary for NAPHAZOLINE
| US Patents: | 0 |
| Applicants: | 2 |
| NDAs: | 3 |
| DailyMed Link: | NAPHAZOLINE at DailyMed |
US Patents and Regulatory Information for NAPHAZOLINE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rising | NAPHAZOLINE HYDROCHLORIDE | naphazoline hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 083590-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Altaire Pharms Inc | NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE | naphazoline hydrochloride; pheniramine maleate | SOLUTION/DROPS;OPHTHALMIC | 078208-001 | Sep 27, 2010 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| Rising | NAPHAZOLINE HYDROCHLORIDE AND PHENIRAMINE MALEATE | naphazoline hydrochloride; pheniramine maleate | SOLUTION/DROPS;OPHTHALMIC | 202795-001 | Jan 24, 2013 | OTC | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
